These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 23732900)
1. Influenza vaccines in low and middle income countries: a systematic review of economic evaluations. Ott JJ; Klein Breteler J; Tam JS; Hutubessy RC; Jit M; de Boer MR Hum Vaccin Immunother; 2013 Jul; 9(7):1500-11. PubMed ID: 23732900 [TBL] [Abstract][Full Text] [Related]
2. Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022. Gharpure R; Chard AN; Cabrera Escobar M; Zhou W; Valleau MM; Yau TS; Bresee JS; Azziz-Baumgartner E; Pallas SW; Lafond KE PLoS Med; 2024 Jan; 21(1):e1004333. PubMed ID: 38181066 [TBL] [Abstract][Full Text] [Related]
3. A systematic review of economic evaluations of seasonal influenza vaccination for the elderly population in the European Union. Shields GE; Elvidge J; Davies LM BMJ Open; 2017 Jun; 7(6):e014847. PubMed ID: 28601824 [TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis. Lugnér AK; van Boven M; de Vries R; Postma MJ; Wallinga J BMJ; 2012 Jul; 345():e4445. PubMed ID: 22791791 [TBL] [Abstract][Full Text] [Related]
6. Costs and effectiveness of influenza vaccination: a systematic review. D'Angiolella LS; Lafranconi A; Cortesi PA; Rota S; Cesana G; Mantovani LG Ann Ist Super Sanita; 2018; 54(1):49-57. PubMed ID: 29616674 [TBL] [Abstract][Full Text] [Related]
7. WHO guide on the economic evaluation of influenza vaccination. Newall AT; Chaiyakunapruk N; Lambach P; Hutubessy RCW Influenza Other Respir Viruses; 2018 Mar; 12(2):211-219. PubMed ID: 29024434 [TBL] [Abstract][Full Text] [Related]
8. Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations. Gatwood J; Meltzer MI; Messonnier M; Ortega-Sanchez IR; Balkrishnan R; Prosser LA Drugs; 2012 Jan; 72(1):35-48. PubMed ID: 22191794 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States. Prosser LA; Lavelle TA; Fiore AE; Bridges CB; Reed C; Jain S; Dunham KM; Meltzer MI PLoS One; 2011; 6(7):e22308. PubMed ID: 21829456 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department. Hart RJ; Stevenson MD; Smith MJ; LaJoie AS; Cross K JAMA Pediatr; 2018 Jan; 172(1):e173879. PubMed ID: 29114729 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysis. Breteler JK; Tam JS; Jit M; Ket JC; De Boer MR Vaccine; 2013 Oct; 31(45):5168-77. PubMed ID: 24012574 [TBL] [Abstract][Full Text] [Related]
12. Seasonal influenza vaccination in Kenya: an economic evaluation using dynamic transmission modelling. Dawa J; Emukule GO; Barasa E; Widdowson MA; Anzala O; van Leeuwen E; Baguelin M; Chaves SS; Eggo RM BMC Med; 2020 Aug; 18(1):223. PubMed ID: 32814581 [TBL] [Abstract][Full Text] [Related]
13. Systematic review of economic evaluations of preparedness strategies and interventions against influenza pandemics. Pérez Velasco R; Praditsitthikorn N; Wichmann K; Mohara A; Kotirum S; Tantivess S; Vallenas C; Harmanci H; Teerawattananon Y PLoS One; 2012; 7(2):e30333. PubMed ID: 22393352 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review. Ozawa S; Mirelman A; Stack ML; Walker DG; Levine OS Vaccine; 2012 Dec; 31(1):96-108. PubMed ID: 23142307 [TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness of influenza vaccination in elderly Australians: an exploratory analysis of the vaccine efficacy required. Newall AT; Dehollain JP Vaccine; 2014 Mar; 32(12):1323-5. PubMed ID: 24486359 [TBL] [Abstract][Full Text] [Related]
16. Global economic evaluations of rotavirus vaccines: A systematic review. Kotirum S; Vutipongsatorn N; Kongpakwattana K; Hutubessy R; Chaiyakunapruk N Vaccine; 2017 Jun; 35(26):3364-3386. PubMed ID: 28504193 [TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands. de Boer PT; Nagy L; Dolk FCK; Wilschut JC; Pitman R; Postma MJ Value Health; 2021 Jan; 24(1):19-31. PubMed ID: 33431149 [TBL] [Abstract][Full Text] [Related]
18. [Cost-effectiveness of vaccines for the prevention of seasonal influenza in different age groups: a systematic review]. Valcárcel Nazco C; García Lorenzo B; Del Pino Sedeño T; García Pérez L; Brito García N; Linertová R; Ferrer Rodríguez J; Imaz Iglesia I; Serrano Aguilar P Rev Esp Salud Publica; 2018 Oct; 92():. PubMed ID: 30327454 [TBL] [Abstract][Full Text] [Related]
19. [Influenza vaccination in the elderly population in Mexico: economic considerations]. Gutiérrez JP; Bertozzi SM Salud Publica Mex; 2005; 47(3):234-9. PubMed ID: 16104466 [TBL] [Abstract][Full Text] [Related]
20. The Cost of Interventions to Increase Influenza Vaccination: A Systematic Review. Anderson LJ; Shekelle P; Keeler E; Uscher-Pines L; Shanman R; Morton S; Aliyev G; Nuckols TK Am J Prev Med; 2018 Feb; 54(2):299-315. PubMed ID: 29362167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]